Finding leprosy and lymphatic filariasis (LF) cases early is paramount in preventing disability, reducing the impact on mental health and fostering good wellbeing for people affected.
Through Lepra’s work on active case detection and ongoing support, we reach remote, rural communities where there is extremely limited healthcare provision.
Once diagnosed, our next priority for people affected by leprosy is to ensure they have free access to healthcare services, so they may begin treatment and rehabilitation. Part of that journey is supporting people affected by leprosy and LF to develop self-care skills - skills that can be used throughout their lifetime.
Leprosy and LF are two of ten neglected tropical diseases (NTDs) recognised by the World Health Organization which show symptoms on the skin. Although skin-related NTDs can attract prejudice, it also makes finding and referring for diagnosis easier.
Combining active case-finding for all skin-related NTDs, at the same time, can benefit all people affected by NTDs. This, together with dedicated skin NTD focussed training for health workers, can save scarce resources, providing a complete and connected approach to skin NTD healthcare.
It can also reduce prejudice towards people affected by leprosy, in particular.
In Bihar, a state in India, five skin NTDs are commonly found in the community: leprosy, LF, cutaneous leishmaniasis (CL), post-kala azar dermal leishmaniasis (PKDL), and scabies. The capacity of the health systems is extremely limited and national guidelines are sporadic. Only leprosy, LF, and PKDL have national protocols for disease control and management.
Working with our partners, Effect Hope, the ASPIRE project established in 2021 in the Jamui District of Bihar, aims to integrate health and community responses to address leprosy LF, PKDL, CL and scabies.
This is an innovative project that models a combined approach to early case detection as well as disease management through the entire continuum of care.
ASPIRE actively involves the community, strengthens health systems, and improves coordination across government non-health and health sectors including the World Health Organisation.
Together with global health charity Effect Hope, we provide:
People affected by the five skin-NTDs will receive the healthcare and support of the project, with health care workers being trained to care for them. The number of direct beneficiaries is estimated at 5,000 people.
The ASPIRE project will:
In just three years, ASPIRE reached more than 2 million people through awareness campaigns, screened 1.2 million people, diagnosed 9,884 new cases and trained 2,500 frontline health workers to recognised the signs and symptoms of NTDs; proving that this is a model ready to be scaled up and replicated across states.
In September 2025, a local photographer visited the ASPIRE project in Bihar, to capture images showing the vital work carried out by LEPRA and some of the people who are benefitting from the project's activity in the district. View the photo gallery here.
From July 2026 to June 2027, efforts will be concentrated on:
From July 2027, it is planned that the ASPIRE model will be replicated in up to three districts.
Your support changes lives. A gift of £38 can provide a village exhibition, helping to reach 100 people with important health information and education. Donate today!